Sermorelin dosage: how much to take and when to adjust

Last updated 2026-07-24

What is the standard sermorelin dose for adults?

The standard sermorelin dose for most adults is 200-300 mcg per day, administered as a single subcutaneous injection at bedtime ^[1]. This range emerged from clinical use of Geref, the FDA-approved sermorelin formulation discontinued in 2008, and has carried forward into compounded prescribing ^[2]. A typical prescriber starts you at 200-250 mcg. After 8-12 weeks, they review your IGF-1 blood levels and symptom response. If IGF-1 has moved into the target range (usually the upper half of age-adjusted normal) and you report improved sleep, recovery, or body composition, the dose stays put. If response is weak and IGF-1remains low, the dose may increase to 300 mcg. Doses above 300 mcg rarely offer additional benefit because the pituitary's growth hormone-releasing hormone receptors saturate; you're not amplifying the signal, you're just wasting peptide ^[3]. Some protocols use weight-based calculation, particularly for patients over 220 pounds. A common formula is 2.5-3.0 mcg per kilogram of body weight. A 200-pound adult (91 kg) would calculate to roughly 230-275 mcg, which lands squarely in the standard range. Lighter adults sometimes start at 150-200 mcg. The weight-based approach provides a rational starting point, but individual pituitary sensitivity varies enough that dosing ultimately hinges on measured IGF-1 response, more than the math. Children and adolescents with confirmed growth hormone deficiency receive higher weight-based doses, often 30 mcg/kg subcutaneously at bedtime when sermorelin is used diagnostically ^[1]. Adult dosing for off-label use is far more conservative because the goal is gentle upregulation of a system that still functions, not replacement of absent hormone.

How do you calculate the right starting dose?

Calculating your starting dose begins with a baseline IGF-1 blood test and a conversation about your goals. Your prescriber is looking for where you sit within the age-adjusted reference range. IGF-1 declines steadily after age 30; a level that's normal for a 25-year-old would be high for someone 50 ^[4]. If your IGF-1 is in the lower third of the normal range for your age, 200-250 mcg is a typical start. If you're just below the reference range, some clinicians begin at 250-300 mcg. Weight influences starting dose, especially at the extremes. The 2.5-3.0 mcg/kg rule gives structure:

Why does timing matter for sermorelin dosage?

Sermorelin works by mimicking growth hormone-releasing hormone, which the hypothalamus pulses throughout the day. The largest natural pulse happens 1-2 hours after you fall asleep, peaking during slow-wave sleep ^[5]. If you inject sermorelin at bedtime, you're amplifying that endogenous pulse. If you inject it at noon, you're adding a signal when the pituitary is already quiet, and the growth hormone response is blunted. The Geref package insert specified bedtime dosing for this reason ^[2]. Clinical observation since then has confirmed it: people who dose sermorelin in the morning report weaker subjective effects and smaller IGF-1 increases than those who dose at night, even at identical mcg amounts. You inject 15-30 minutes before you plan to lie down. The peptide has a very short half-life, around 10-20 minutes in circulation ^[6]. It doesn't need to hang around; it just needs to hit GHRH receptors on pituitary somatotrophs during the natural pulse window. Growth hormone itself then rises over the next 30-90 minutes, peaks, and clears. IGF-1, the longer-lived downstream mediator, stays elevated for 12-18 hours, which is why a single daily dose sustains effect. Some people ask about splitting the dose, taking 100-150 mcg twice daily (morning and night) to create two pulses. The data supporting this approach is thin. One small study in elderly men found that multiple daily pulses of GHRH produced a more youthful 24-hour growth hormone profile than a single large pulse ^[7], but the logistics are annoying and most prescribers stick with once-nightly dosing unless the patient has a specific reason to experiment. If you miss a dose, take it the next night. Don't double up. The goal is consistency over weeks and months, not perfect daily coverage.

How long until you see results at a given dose?

The earliest subjective change is usually sleep quality. Many people report deeper sleep and fewer middle-of-the-night awakenings within the first 1-2 weeks at 200-250 mcg. This isn't placebo; growth hormone directly affects sleep architecture, increasing slow-wave sleep duration ^[8]. If you track it with a wearable, you may see the effect in your sleep scores before you feel it. IGF-1 levels begin to rise within 2-4 weeks but plateau around 8-12 weeks ^[3]. That's when your prescriber retests. If IGF-1 has moved into the upper half of the age-adjusted range and you're noticing improved recovery or body composition, the dose is working. If IGF-1 barely budged, the dose may be too low or something else is limiting response (poor sleep, high cortisol, inadequate protein intake). Body composition changes, less abdominal fat, slightly better muscle definition, take 3-6 months at a stable effective dose. These shifts are subtle compared to what exogenous HGH produces. Sermorelin stimulates your own pulsatile growth hormone release; it doesn't flood the system the way injected HGH does. If you're expecting dramatic recomposition in 90 days, you'll be disappointed. If you're looking for a 5-10% improvement in lean mass and fat distribution over six months alongside training and diet, that's realistic ^[9]. Skin, hair, and subjective energy follow a similar timeline: noticeable around month 3-4, more pronounced by month 6. Nobody has great placebo-controlled data on these endpoints because the original Geref trials focused on growth hormone secretion and IGF-1, not cosmetic outcomes. What we have is consistent anecdotal reporting from prescribers and patients, which isn't nothing but isn't a clinical trial either.

When should you adjust your sermorelin dose?

You adjust based on IGF-1 response and tolerability, not based on feeling. The first checkpoint is 8-12 weeks. Your prescriber orders another IGF-1 test and asks about sleep, recovery, side effects, and any body composition changes. If IGF-1 has risen into the target zone (typically 200-300 ng/mL for adults, age-adjusted), the dose stays. If IGF-1 is still in the lower third of normal and you report no subjective benefit, the dose increases by 50 mcg. If you started at 200 mcg and IGF-1 barely moved, stepping to 250 mcg is standard. Retest at 8 weeks. If 250 mcg brings IGF-1 into range, you stay there. If it's still flat, 300 mcg is the ceiling for most prescribers. Above that, you're fighting diminishing returns and the likely problem is not dose but one of the following: your pituitary is exhausted (chronic stress, poor sleep, overtraining), your nutrition doesn't support IGF-1 production (low protein, calorie deficit), or you're on a medication that blunts growth hormone (high-dose corticosteroids, chronic opioids) ^[10]. You also adjust down if side effects appear. Injection-site redness, headaches, or flushing are the most common complaints. If 250 mcg gives you a headache every night, dropping to 200 mcg and reassessing in a month is smarter than pushing through. Some people find their sweet spot at 150-200 mcg and get 80% of the benefit with zero side effects. That's a win. Once you've dialed in a dose that produces target IGF-1 and feels sustainable, you retest every 6 months. IGF-1 can drift up or down with changes in sleep, diet, training load, or aging. If it climbs above the reference range, you're overdoing it and the dose should come down. Chronically supraphysiologic IGF-1 is a theoretical cancer risk; nobody wants to live there ^[11]. Some protocols cycle sermorelin, using it 5 days on and 2 days off each week, or 3 months on and 1 month off. The rationale is to prevent receptor downregulation. There's no strong evidence that continuous use at standard doses causes desensitization, but cycling is popular in performance and longevity circles. If you try it, expect IGF-1 to dip slightly during off periods.

What happens if you take too much sermorelin?

Taking too much sermorelin doesn't produce proportionally better results because the pituitary response plateaus. A study in healthy older adults found that 1 mcg/kg (roughly 70-90 mcg for most people) stimulated growth hormone release, 2 mcg/kg doubled the effect, but 4 mcg/kg and 8 mcg/kg produced nearly identical responses ^[12]. The dose-response curve flattens. At standard doses of 200-300 mcg, you're already near the top of that curve. Pushing to 500 mcg doesn't give you twice the IGF-1; it gives you the same IGF-1 and a higher chance of side effects. The most common acute effect of excessive dosing is flushing and headache. Sermorelin causes transient vasodilation, and higher doses amplify this. Some people also report nausea or dizziness. These symptoms resolve within an hour as the peptide clears. There are no published cases of serious acute toxicity from sermorelin overdose in adults. Chronic overdosing, staying above 300 mcg for months with resulting supraphysiologic IGF-1, carries the same theoretical risks as exogenous growth hormone: fluid retention, joint discomfort, insulin resistance, and possible increased cancer risk ^[11]. The difference is that sermorelin's short half-life and dependence on pituitary response create a natural ceiling. You can't easily push IGF-1 to the levels that bodybuilders achieve with recombinant HGH. If you accidentally inject twice the intended dose one night, you'll probably feel flushed and get a mild headache. Skip the next dose, resume your normal schedule the following night, and mention it to your prescriber at your next check-in. One double dose doesn't cause lasting harm.

How does sermorelin dosage compare to HGH dosage?

Sermorelin and HGH are not dosed on the same scale. HGH is recombinant human growth hormone itself, injected exogenously. Typical HGH doses for adult growth hormone deficiency replacement are 0.2-0.5 mg per day (200-500 mcg) ^[13]. Anti-aging and performance protocols often use 1-4 IU per day, which translates to roughly 0.33-1.33 mg. Sermorelin doses of 200-300 mcg don't deliver 200-300 mcg of growth hormone; they stimulate your pituitary to release growth hormone in a pulsatile pattern. The amount of endogenous GH released per sermorelin dose varies by individual and by pituitary reserve. A healthy pituitary might release 1-2 mcg/kg of growth hormone in response to 200 mcg of sermorelin ^[12], so a 180-pound adult might release 80-160 mcg of GH per pulse. That's far less than someone injecting 1 mg of exogenous HGH, which is why sermorelin produces gentler effects. Because sermorelin works through your own physiology, it preserves the pulsatile pattern. Growth hormone is supposed to spike and clear, not stay elevated all day. Exogenous HGH flattens that pattern, which may disrupt feedback loops over time. Sermorelin also doesn't suppress your endogenous production the way exogenous HGH does; when you stop sermorelin, your natural GHRH and GH secretion resume immediately. When you stop HGH after long-term use, your pituitary can take weeks or months to restart ^[14]. The practical difference: if you want the strong anabolic and lipolytic effects of supraphysiologic growth hormone, sermorelin won't get you there. If you want to restore a more youthful GH pulse without shutting down your axis, sermorelin at standard doses is the conservative choice. For a detailed side-by-side, see the broader sermorelin overview.

Does your age or weight change the optimal dose?

Age affects pituitary sensitivity and baseline IGF-1, which indirectly influences dosing. A 35-year-old with normal sleep and low-normal IGF-1 may respond briskly to 200 mcg, reaching target levels within 8 weeks. A 60-year-old with the same starting IGF-1 often needs 250-300 mcg to achieve a similar increase because pituitary GHRH receptor density declines with age and chronic low-grade inflammation blunts GH secretion ^[15]. The dose range doesn't change radically, but older adults cluster toward the higher end. Weight matters more for distribution and receptor load. Heavier individuals have more tissue mass expressing IGF-1 receptors, so the same absolute increase in IGF-1 is spread over a larger body. The 2.5-3.0 mcg/kg guideline reflects this. A 130-pound adult may see strong effects at 150-200 mcg, while a 230-pound adult needs 250-300 mcg for comparable subjective benefit. That said, once you hit 300 mcg, adding more dose for additional weight rarely helps; you're better off optimizing sleep and nutrition. Gender may introduce subtle differences, though the data is sparse. Women tend to have slightly higher baseline GH secretion and pulsatility than men, and some studies suggest women achieve target IGF-1 levels at the lower end of the dosing range ^[16]. In clinical practice, prescribers start men and women at the same weight-adjusted dose and adjust based on individual response rather than assuming a gender-specific protocol. Body composition also matters. Higher body fat percentage is associated with blunted GH secretion ^[17]. If you're carrying excess fat, you may need the higher end of the dose range to overcome that suppression, and sermorelin's effectiveness improves as you lose fat. It's a feedback loop: better GH secretion helps fat loss, fat loss improves GH secretion.

How do you dose sermorelin if you're stacking it with other peptides?

Many prescribers combine sermorelin with ipamorelin, a growth hormone secretagogue that works through a different receptor (ghrelin receptor). The combination produces a larger GH pulse than either peptide alone . Typical stacking protocol: 200-250 mcg sermorelin + 200-250 mcg ipamorelin, both injected at bedtime in the same syringe or sequentially. Some compounding pharmacies blend them into a single vial. When you stack, you often start at the lower end of the sermorelin dose range because the combined effect amplifies results. If 250 mcg sermorelin alone brings your IGF-1 to mid-range, 200 mcg sermorelin + 200 mcg ipamorelin might push it higher. You retest at 8 weeks and adjust the blend. If IGF-1 climbs above range or you develop side effects, you drop both peptides by 50 mcg rather than trying to isolate which one to reduce. CJC-1295 (the non-DAC version, also called Modified GRF 1-29) is another stacking partner. It's a longer-acting GHRH analog, and typical dosing is 100 mcg alongside 200 mcg sermorelin and 200 mcg ipamorelin. This three-peptide combination is popular in anti-aging and performance protocols, though the evidence base is thin. You're layering mechanisms (GHRH, ghrelin, extended GHRH analog), but you're also multiplying cost and injection complexity. If you're stacking, work with a prescriber who monitors IGF-1 closely. The risk isn't acute toxicity; it's drifting into supraphysiologic territory and staying there for months. Providers familiar with peptide stacks, often found through telehealth platforms like Sermorelin Co, which partners with experienced compounding pharmacies, will walk you through the dose adjustments and testing schedule. For guidance on choosing a knowledgeable provider, the sermorelin reviews piece covers what to look for.

What should you do if your current dose stops working?

If sermorelin stops producing benefit after months of stable effect, the first question is whether anything else changed. Did your sleep deteriorate? Did you start a new medication? Did you cut calories hard or ramp up training volume? All of these can blunt GH responsiveness independent of the sermorelin dose. The second step is retesting IGF-1. If it has drifted back down to baseline despite consistent dosing, true desensitization is possible but uncommon at standard doses. More often, the problem is external: chronic stress spiking cortisol, inadequate protein intake (IGF-1 production requires substrate), or overtraining suppressing the hypothalamic-pituitary axis ^[10]. Fix those, and response returns without changing the dose. If IGF-1 is still elevated but you feel nothing, the issue may be that you've adapted to the new normal. The subjective benefits of sermorelin, better sleep, faster recovery, are most noticeable in the first few months. After six months at stable IGF-1, your body recalibrates. This isn't treatment failure; it's homeostasis. One way to test it: stop sermorelin for 4 weeks (with your prescriber's approval) and see if sleep or recovery deteriorate. If they do, the peptide was working; you'd just stopped noticing. If IGF-1 has genuinely fallen and external factors are optimized, a dose increase of 50 mcg is reasonable. Retest in 8 weeks. If that fails to restore response, cycling off for 4-8 weeks and then restarting at the original dose sometimes resets sensitivity. Some clinicians rotate between sermorelin and a stacked protocol (sermorelin + ipamorelin) every 3-4 months to avoid monotony at the receptor level, though the data supporting this is anecdotal. Persistent poor response despite dose adjustments and lifestyle optimization may mean your pituitary reserve is limited. At that point, the conversation shifts to whether exogenous HGH is worth considering for true growth hormone deficiency replacement, which is a different decision tree.

Frequently asked questions

Can you take sermorelin every other day instead of daily?

You can, but daily dosing produces more consistent IGF-1 levels and subjective benefit. Sermorelin's half-life is under 20 minutes, so it doesn't accumulate. Every-other-day dosing is sometimes used for cost savings or to reduce injection frequency, but most prescribers recommend daily use for the first 3-6 months to establish stable response. If you're responding well and want to experiment with less frequent dosing, discuss it with your provider and recheck IGF-1 after 8 weeks.

What's the maximum safe dose of sermorelin?

Most prescribers cap sermorelin at 300 mcg per day because pituitary response plateaus and higher doses offer minimal additional benefit. The original Geref studies used up to 500 mcg in some diagnostic protocols without serious adverse events, but chronic dosing above 300 mcg increases side effects (flushing, headache) without proportional IGF-1 gain. There's no established toxic dose in adults; safety limits are defined by futility and discomfort rather than danger.

Should you inject sermorelin in the morning or at night?

Inject sermorelin at bedtime, 15-30 minutes before sleep. Growth hormone's natural peak occurs 1-2 hours after you fall asleep during slow-wave sleep. Sermorelin amplifies that endogenous pulse. Morning dosing produces a weaker GH response because the hypothalamus isn't pulsing GHRH at that time. Clinical and anecdotal data consistently favor nighttime administration for both IGF-1 response and subjective benefits like sleep quality.

How many days per week should you use sermorelin?

Most protocols use sermorelin 7 days per week for the first 3-6 months. Some practitioners then shift to 5 days on, 2 days off to allow periodic receptor rest, though evidence supporting this is limited. Daily use produces the most stable IGF-1 levels. If cost or injection fatigue is an issue, 5-6 days per week is a reasonable compromise, but expect slightly lower average IGF-1.

Does sermorelin dose need to increase over time?

Not necessarily. If your IGF-1 stays in the target range and you continue seeing benefit, the dose remains stable. Some people stay at 200-250 mcg for years. Dose increases are driven by declining IGF-1 response or inadequate initial effect, not by time alone. If lifestyle factors (sleep, stress, training) change, those may require adjustment, but the peptide dose itself doesn't need automatic escalation.

Can you split your sermorelin dose into two injections per day?

You can inject sermorelin twice daily (e.g., 100-150 mcg morning and night) to mimic more frequent GH pulses, but most prescribers stick with once-nightly dosing for simplicity and because nighttime dosing matches the body's natural GH peak. Split dosing may produce a more physiologic 24-hour GH profile in theory, but practical benefit over single nighttime dosing is unproven. If you want to experiment, discuss timing and total daily dose with your provider.

What happens if you miss a sermorelin dose?

If you miss a dose, take your normal dose the next night. Don't double up. Sermorelin works by amplifying your natural GH pulse; missing one night doesn't erase prior progress. IGF-1 has a half-life of 12-16 hours, so levels dip slightly but don't crash after a single missed dose. Consistency over weeks and months matters more than perfect daily adherence.

How much does sermorelin dose cost per month?

Cost scales with dose and source. Compounded sermorelin typically costs $200-400 per month for a 200-250 mcg daily dose, depending on the pharmacy and whether you're stacking it with other peptides. Higher doses (300 mcg) push toward the upper end of that range. Telehealth providers and compounding pharmacies often offer subscription pricing that includes prescriber oversight and retesting. The sermorelin dosage chart breaks down cost by dose tier.

Is 100 mcg of sermorelin enough to see results?

100 mcg is below the typical effective range for most adults. While it may stimulate some GH release, clinical experience and dosing studies suggest 200-300 mcg is needed to produce measurable IGF-1 increases and subjective benefits like improved sleep and recovery. Very light individuals (under 130 pounds) or those with highly sensitive pituitaries might respond to 100-150 mcg, but this is uncommon. If cost or tolerability limits you to 100 mcg, try it for 8 weeks and recheck IGF-1, but expect modest results.

Can you use a sermorelin dosage calculator to find your dose?

A sermorelin dosage calculator can estimate a weight-based starting dose (typically 2.5-3.0 mcg/kg), but it's only a starting point. Your actual dose depends on baseline IGF-1, age, goals, pituitary sensitivity, and how you tolerate the peptide. Prescribers use calculators as input, then adjust based on 8-12 week follow-up labs. No algorithm replaces individualized prescribing and monitoring.

Should you adjust sermorelin dose when cutting or bulking?

Your sermorelin dose typically stays stable whether you're in a calorie deficit (cutting) or surplus (bulking), but your response may vary. Calorie restriction can blunt GH secretion and IGF-1 production, so some people need a slightly higher dose during a cut to maintain IGF-1 in range. Conversely, adequate protein and calories during a bulk support IGF-1 synthesis, and you may get more from the same dose. Recheck IGF-1 if you make a major diet change and adjust dose if levels drift out of target.

How long should you stay on sermorelin at a given dose?

Most protocols run sermorelin continuously for 6-12 months, then reassess. If IGF-1 and symptoms are stable, you can continue indefinitely at the same dose with 6-month recheck labs. Some practitioners cycle off for 1-2 months per year to assess whether benefit persists and to allow theoretical receptor recovery, though evidence for cycling is anecdotal. Duration on a specific dose is less important than whether that dose continues producing target IGF-1 without side effects.

Do you need to refrigerate sermorelin after dosing?

Reconstituted sermorelin must be refrigerated at 2-8°C (36-46°F) between doses. After you draw your dose into the syringe, you can leave it at room temperature for the few minutes it takes to inject, but return the vial to the refrigerator immediately. Sermorelin degrades quickly at room temperature; a vial left out overnight loses potency. If you're traveling, use a small insulated case with a cold pack. Proper storage ensures each dose delivers the intended mcg of active peptide.

Sources

1. FDA, Drugs@FDA database, Geref NDA 019335: Geref (sermorelin acetate) was discontinued by the manufacturer in 2008, not withdrawn for safety or efficacy reasons
2. Journal of Clinical Endocrinology & Metabolism, Corpas et al. 1992, PMID: 1639945: IGF-1 increases plateau by 8-12 weeks of sermorelin therapy in older adults; dose-response curve flattens above 2 mcg/kg
3. Mayo Clinic Laboratories, IGF-1 test information: IGF-1 reference ranges are age-adjusted; levels decline steadily after age 30
4. National Institute of Neurological Disorders and Stroke, Brain Basics: Understanding Sleep: Peak endogenous growth hormone secretion occurs 1-2 hours after sleep onset during slow-wave sleep
5. Journal of Endocrinology, Guillemin et al. 1984, PMID: 6423622: Sermorelin (GHRH 1-29) has a plasma half-life of approximately 10-20 minutes
6. Journal of Clinical Endocrinology & Metabolism, Veldhuis et al. 2004, PMID: 14671216: Multiple daily GHRH pulses restore more youthful 24-hour GH secretion patterns in elderly men compared to single large pulse
7. Sleep Medicine Reviews, Van Cauter et al. 2000, PMID: 12531146: Growth hormone administration increases slow-wave sleep duration and quality
8. New England Journal of Medicine, Rudman et al. 1990, PMID: 2355952: Six months of growth hormone therapy in elderly men produced 8.8% increase in lean body mass and 14.4% decrease in adipose tissue mass
9. Endocrine Reviews, Casanueva et al. 2010, PMID: 20663880: Chronic stress, poor sleep, overtraining, high-dose corticosteroids, and chronic opioids suppress growth hormone secretion
10. Journal of Clinical Endocrinology & Metabolism, Renehan et al. 2004, PMID: 14764780: Elevated IGF-1 is associated with increased cancer risk in observational studies; causality remains debated
11. Journal of Clinical Endocrinology & Metabolism, Ghigo et al. 1993, PMID: 8408806: Dose-response relationship for GHRH shows plateau at higher doses; 4 mcg/kg and 8 mcg/kg produce similar GH responses
12. Endocrine Society, Growth Hormone Deficiency in Adults Clinical Practice Guideline: Adult GH replacement therapy typically starts at 0.2-0.5 mg per day, adjusted based on IGF-1 response
13. Journal of Clinical Endocrinology & Metabolism, Hoffman et al. 2004, PMID: 15126565: Endogenous GH secretion suppression during exogenous GH therapy; pituitary recovery takes weeks to months after cessation
14. Endocrine Reviews, Bartke et al. 2013, PMID: 23271674: Age-related decline in pituitary GHRH receptor density and chronic inflammation blunt GH secretion in older adults
15. Journal of Clinical Endocrinology & Metabolism, Clasey et al. 2001, PMID: 11158019: Women demonstrate higher baseline GH secretion and pulsatility than men across the lifespan
16. Journal of Clinical Endocrinology & Metabolism, Veldhuis et al. 1995, PMID: 7650161: Higher body fat percentage is associated with blunted GH secretion in response to GHRH
17. Growth Hormone & IGF Research, Bowers et al. 2004, PMID: 15279057: Combination of GHRH and ghrelin receptor agonists produces enhanced growth hormone release greater than either alone